125 related articles for article (PubMed ID: 10554162)
1. Synthesis of Bcl-2 in response to anthracycline treatment may contribute to an apoptosis-resistant phenotype in leukemic cell lines.
Durrieu F; Belaud-Rotureau MA; Lacombe F; Dumain P; Reiffers J; Boisseau MR; Bernard P; Belloc F
Cytometry; 1999 Jun; 36(2):140-9. PubMed ID: 10554162
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines.
Nuessler V; Stötzer O; Gullis E; Pelka-Fleischer R; Pogrebniak A; Gieseler F; Wilmanns W
Leukemia; 1999 Nov; 13(11):1864-72. PubMed ID: 10557064
[TBL] [Abstract][Full Text] [Related]
3. The role of BCL-2 and bax protein in monocyte-mediated apoptosis in human leukemic cell lines.
Legdeur MC; Bontje PM; Ossenkoppele GJ; Beelen RH; van de Loosdrecht AA; Broekhoven MG; Langenhuijsen MM; Thijsen SF; Hofstee H; Schuurhuis GJ
Exp Hematol; 1996 Nov; 24(13):1530-9. PubMed ID: 8950237
[TBL] [Abstract][Full Text] [Related]
4. A flow cytometric method to detect apoptosis-related protein expression in minimal residual disease in acute myeloid leukemia.
van Stijn A; Kok A; van der Pol MA; Feller N; Roemen GM; Westra AH; Ossenkoppele GJ; Schuurhuis GJ
Leukemia; 2003 Apr; 17(4):780-6. PubMed ID: 12682637
[TBL] [Abstract][Full Text] [Related]
5. Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells.
Huang Y; Ibrado AM; Reed JC; Bullock G; Ray S; Tang C; Bhalla K
Leukemia; 1997 Feb; 11(2):253-7. PubMed ID: 9009089
[TBL] [Abstract][Full Text] [Related]
6. The combination regimen of idarubicin and taxotere is effective against human drug-resistant leukemic cell lines.
Majlessipour F; Avramis IA; Kwock R; Weinberg KI; Avrami VI
Anticancer Res; 2002; 22(3):1361-8. PubMed ID: 12168812
[TBL] [Abstract][Full Text] [Related]
7. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
[TBL] [Abstract][Full Text] [Related]
8. Modulation of idarubicin-induced apoptosis in human acute myeloid leukemia blasts by all-trans retinoic acid, 1,25(OH)2 vitamin D3, and granulocyte-macrophage colony-stimulating factor.
Ketley NJ; Allen PD; Kelsey SM; Newland AC
Blood; 1997 Dec; 90(11):4578-87. PubMed ID: 9373269
[TBL] [Abstract][Full Text] [Related]
9. Impact of the expression of P glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat shock protein 27 on response to induction therapy and long-term survival in patients with de novo acute myeloid leukemia.
Kasimir-Bauer S; Beelen D; Flasshove M; Noppeney R; Seeber S; Scheulen ME
Exp Hematol; 2002 Nov; 30(11):1302-8. PubMed ID: 12423683
[TBL] [Abstract][Full Text] [Related]
10. Multidrug resistance modulators PSC 833 and CsA show differential capacity to induce apoptosis in lymphoid leukemia cell lines independently of their MDR phenotype.
Lopes EC; Garcia M; Benavides F; Shen J; Conti CJ; Alvarez E; Hajos SE
Leuk Res; 2003 May; 27(5):413-23. PubMed ID: 12620293
[TBL] [Abstract][Full Text] [Related]
11. Modulation of resistance to idarubicin by the cyclosporin PSC 833 (valspodar) in multidrug-resistant cells.
Lacayo NJ; Duran GE; Sikic BI
J Exp Ther Oncol; 2003; 3(3):127-35. PubMed ID: 14641819
[TBL] [Abstract][Full Text] [Related]
12. Expression of bcl-2 and bax in TGF-beta 1-induced apoptosis of L1210 leukemic cells.
Motyl T; Grzelkowska K; Zimowska W; Skierski J; Wareski P; Płoszaj T; Trzeciak L
Eur J Cell Biol; 1998 Apr; 75(4):367-74. PubMed ID: 9628323
[TBL] [Abstract][Full Text] [Related]
13. Influence of Bcl-2 overexpression on the ceramide pathway in daunorubicin-induced apoptosis of leukemic cells.
Allouche M; Bettaieb A; Vindis C; Rousse A; Grignon C; Laurent G
Oncogene; 1997 Apr; 14(15):1837-45. PubMed ID: 9150390
[TBL] [Abstract][Full Text] [Related]
14. Study of apoptosis-related responses of leukemic blast cells to in vitro anthracycline treatment.
Belaud-Rotureau MA; Durrieu F; Labroille G; Lacombe F; Fitoussi O; Agape P; Marit G; Reiffers J; Belloc F
Leukemia; 2000 Jul; 14(7):1266-75. PubMed ID: 10914552
[TBL] [Abstract][Full Text] [Related]
15. Induction of chemoresistance in HL-60 cells concomitantly causes a resistance to apoptosis and the synthesis of P-glycoprotein.
Campone M; Vavasseur F; Le Cabellec MT; Meflah K; Vallette FM; Oliver L
Leukemia; 2001 Sep; 15(9):1377-87. PubMed ID: 11516098
[TBL] [Abstract][Full Text] [Related]
16. Comparison of idarubicin and daunorubicin regarding intracellular uptake, induction of apoptosis, and resistance.
Lotfi K; Zackrisson AL; Peterson C
Cancer Lett; 2002 Apr; 178(2):141-9. PubMed ID: 11867198
[TBL] [Abstract][Full Text] [Related]
17. Beta-hydroxyisovalerylshikonin induces apoptosis in human leukemia cells by inhibiting the activity of a polo-like kinase 1 (PLK1).
Masuda Y; Nishida A; Hori K; Hirabayashi T; Kajimoto S; Nakajo S; Kondo T; Asaka M; Nakaya K
Oncogene; 2003 Feb; 22(7):1012-23. PubMed ID: 12592388
[TBL] [Abstract][Full Text] [Related]
18. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
Ray S; Bullock G; Nuñez G; Tang C; Ibrado AM; Huang Y; Bhalla K
Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of Bax in ceramide-resistant HL-60 subline.
Sawai H; Kawai S; Domae N
Biochem Biophys Res Commun; 2004 Jun; 319(1):46-9. PubMed ID: 15158440
[TBL] [Abstract][Full Text] [Related]
20. Fas-mediated apoptosis and expression of related genes in human malignant hematopoietic cells.
Kim KM; Lee K; Hong YS; Park HY
Exp Mol Med; 2000 Dec; 32(4):246-54. PubMed ID: 11190279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
